Search Results - "Spillner, Jan W."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Tyrosine kinase inhibitors relax pulmonary arteries in human and murine precision-cut lung slices by Rieg, Annette D, Bünting, Nina A, Cranen, Christian, Suleiman, Said, Spillner, Jan W, Schnöring, Heike, Schröder, Thomas, von Stillfried, Saskia, Braunschweig, Till, Manley, Paul W, Schälte, Gereon, Rossaint, Rolf, Uhlig, Stefan, Martin, Christian

    Published in Respiratory research (06-06-2019)
    “…Tyrosine kinase inhibitors (TKIs) inhibit the platelet derived growth factor receptor (PDGFR) and gain increasing significance in the therapy of proliferative…”
    Get full text
    Journal Article
  2. 2

    Milrinone relaxes pulmonary veins in guinea pigs and humans by Rieg, Annette D, Suleiman, Said, Perez-Bouza, Alberto, Braunschweig, Till, Spillner, Jan W, Schröder, Thomas, Verjans, Eva, Schälte, Gereon, Rossaint, Rolf, Uhlig, Stefan, Martin, Christian

    Published in PloS one (31-01-2014)
    “…The phosphodiesterase-III inhibitor milrinone improves ventricular contractility, relaxes pulmonary arteries and reduces right ventricular afterload. Thus, it…”
    Get full text
    Journal Article
  3. 3

    The effects of hydroxyethyl starch and gelatine on pulmonary cytokine production and oedema formation by Krabbe, Julia, Ruske, Nadine, Braunschweig, Till, Kintsler, Svetlana, Spillner, Jan W., Schröder, Thomas, Kalverkamp, Sebastian, Kanzler, Stephanie, Rieg, Annette D., Uhlig, Stefan, Martin, Christian

    Published in Scientific reports (23-03-2018)
    “…Recently, side effects of plasma expanders like hydroxyethyl starch and gelatine gained considerable attention. Most studies have focused on the kidneys; lungs…”
    Get full text
    Journal Article
  4. 4

    Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation by Menon, Ares K., Götzenich, Andreas, Sassmannshausen, Helena, Haushofer, Marcus, Autschbach, Rüdiger, Spillner, Jan W.

    “…OBJECTIVES Bleeding and thrombo-embolism are two of the most threatening adverse events associated with the use of continuous flow left ventricular assist…”
    Get full text
    Journal Article